Goepfert Christiane, Lutz Vivien, Lünse Svenja, Kittel Sabrina, Wiegandt Katharina, Kammal Michael, Püschel Klaus, Pörtner Ralf
Hamburg University of Technology, Institute of Bioprocess and Biosystems Engineering, Hamburg - Germany.
Int J Artif Organs. 2010 Apr;33(4):204-18.
Cell-based technologies for the repair of cartilage defects usually rely on the expansion of low numbers of chondrocytes isolated from biopsies of healthy cartilage. Proliferating chondrocytes are known to undergo dedifferentiation characterized by downregulation of collagen type II and proteoglycan production, and by upregulation of collagen type I synthesis. Re-expression of cartilage specific matrix components by expanded chondrocytes is therefore critical for successful cartilage repair.
Human articular chondrocytes were expanded on microcarriers Cytodex 3. The growth area was increased by adding empty microcarriers. Added microcarriers were colonized by bead-to-bead transfer of the cells. The chondrocytes were harvested from the microcarriers and characterized by their ability to synthesize collagen type II when cultivated in alginate beads using chondrogenic growth factors. A semi-automatic image analysis technique was developed to determine the fractions of collagen type II and type I positive cells.
The expansion of human articular chondrocytes on microcarriers yielded high cell numbers and propagation rates compared to chondrocytes expanded in flask culture for one passage. The proportion of collagen type II positive cells compared to collagen type I synthesizing cells was increased compared to chondrocytes expanded using conventional methods. The matrix synthesis upon treatment with chondrogenic factors IGF-I and BMP-7 was enhanced whereas TGF-ss had an inhibitory effect on microcarrier expanded chondrocytes.
Expanding human articular chondrocytes on microcarriers omitting subcultivation steps leads to superior ratios of collagen type II to type I forming cells compared to the expansion in conventional monolayer culture.
用于修复软骨缺损的基于细胞的技术通常依赖于从健康软骨活检中分离出的少量软骨细胞的扩增。已知增殖的软骨细胞会发生去分化,其特征是II型胶原蛋白和蛋白聚糖的产生下调,以及I型胶原蛋白合成上调。因此,扩增后的软骨细胞重新表达软骨特异性基质成分对于成功的软骨修复至关重要。
人关节软骨细胞在微载体Cytodex 3上扩增。通过添加空微载体来增加生长面积。添加的微载体通过细胞的珠对珠转移进行定植。从微载体上收获软骨细胞,并在使用软骨生成生长因子的藻酸盐珠中培养时,通过其合成II型胶原蛋白的能力进行表征。开发了一种半自动图像分析技术来确定II型和I型胶原蛋白阳性细胞的比例。
与人关节软骨细胞在培养瓶中传代培养一代相比,在微载体上扩增产生了更高的细胞数量和增殖率。与使用传统方法扩增的软骨细胞相比,合成II型胶原蛋白的细胞与合成I型胶原蛋白的细胞的比例增加。用软骨生成因子IGF-I和BMP-7处理后,基质合成增强,而TGF-β对微载体扩增的软骨细胞有抑制作用。
与传统单层培养扩增相比,在微载体上扩增人关节软骨细胞而省略传代培养步骤会导致形成II型与I型胶原蛋白的细胞比例更高。